TIDD: tool-independent and data-dependent machine learning for peptide identification.

BMC Bioinformatics

Department of Computer Science, Hanyang University, Seoul, 04763, Republic of Korea.

Published: March 2022

Background: In shotgun proteomics, database search engines have been developed to assign peptides to tandem mass (MS/MS) spectra and at the same time post-processing (or rescoring) approaches over the search results have been proposed to increase the number of confident peptide identifications. The most popular post-processing approaches such as Percolator and PeptideProphet have improved rates of peptide identifications by combining multiple scores from database search engines while applying machine learning techniques. Existing post-processing approaches, however, are limited when dealing with results from new search engines because their features for machine learning must be optimized specifically for each search engine.

Results: We propose a universal post-processing tool, called TIDD, which supports confident peptide identifications regardless of the search engine adopted. TIDD can work for any (including newly developed) search engines because it calculates universal features that assess peptide-spectrum match quality while it allows additional features provided by search engines (or users) as well. Even though it relies on universal features independent of search tools, TIDD showed similar or better performance than Percolator in terms of peptide identification. TIDD identified 10.23-38.95% more PSMs than target-decoy estimation for MSFragger, which is not supported by Percolator. TIDD offers an easy-to-use simple graphical user interface for user convenience.

Conclusions: TIDD successfully eliminated the requirement for an optimal feature engineering per database search tool, and thus, can be applied directly to any database search results including newly developed ones.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969291PMC
http://dx.doi.org/10.1186/s12859-022-04640-yDOI Listing

Publication Analysis

Top Keywords

search engines
20
database search
16
machine learning
12
peptide identifications
12
search
11
peptide identification
8
confident peptide
8
post-processing approaches
8
including newly
8
newly developed
8

Similar Publications

Effect of Gut Dysbiosis on Onset of GI Cancers.

Cancers (Basel)

December 2024

Division of Hematology and Oncology, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA.

Dysbiosis in the gut microbiota plays a significant role in GI cancer development by influencing immune function and disrupting metabolic functions. Dysbiosis can drive carcinogenesis through pathways like immune dysregulation and the release of carcinogenic metabolites, and altered metabolism, genetic instability, and pro-inflammatory signalling, contributing to GI cancer initiation and progression. infection and genotoxins released from dysbiosis, lifestyle and dietary habits are other factors that contribute to GI cancer development.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolic syndrome is a growing public health issue globally, particularly linked to diseases like type 2 diabetes, and this study focuses on its prevalence among type 2 diabetic patients in Ethiopia.
  • Researchers analyzed various studies to determine the pooled prevalence and factors contributing to metabolic syndrome, employing robust statistical methods to ensure accuracy and reliability of findings.
  • The study found a significant prevalence of metabolic syndrome among type 2 diabetes patients in Ethiopia, with rates ranging from about 47% to over 59% depending on different diagnostic criteria, and it identified several risk factors associated with the condition.
View Article and Find Full Text PDF

Introduction: There is strong evidence of the substance dependence has a negative impact on key dimensions of health. The scientific evidence suggests that pharmacological treatment could play a fundamental role in its clinical management.

Objective: The aim of this systematic review is to explore the existing pharmacological options for the treatment of substance use disorders.

View Article and Find Full Text PDF

Background: Clinical outcome assessments (COAs) measure how patients feel or function and can be used to understand which patients experience benefits of treatment and which do not. Interpretation of COA data is influenced by how meaningful change is defined. We aimed to compare how different stakeholders define, assess, and use meaningful change for decisions that impact patients.

View Article and Find Full Text PDF

Introduction: Recruitment of participants for intervention studies is challenging. We evaluated the effectiveness and efficiency of a participant recruitment campaign through an online registry for the FINGER-NL study, a multi-domain lifestyle intervention trial targeting cognitively healthy individuals aged 60-79 with dementia prevention potential. Additionally, we explored which recruitment strategy successfully reached individuals from underrepresented groups in research.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!